Methods and compositions using selective cytokine inhibitory drugs for treatment and management of chronic uveitis

摘要

Use of a selective cytokine inhibitory drug selected from cyclopropyl-N-{2[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide, which has the structure (I) as shown herein: and pharmaceutically acceptable salts and solvates thereof; in the preparation of a composition for treating chronic uveitis is disclosed.